ERO1A as a novel biomarker for risk stratification and immunotherapeutic guidance in early-stage lung adenocarcinoma.

PeerJ · 2026 · PMC13282948 · PMID 42328676

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = 0.074so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

Statistical analysis showed a trend toward higher PD-L1 positivity in ERO1A-high patients, although this did not reach statistical significance ( P = 0.074; Fig. 6H ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.